Royal Bank of Canada decreased its stake in shares of BT Group plc (NYSE:BT) by 7.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 862,954 shares of the utilities provider’s stock after selling 69,733 shares during the period. Royal Bank of Canada’s holdings in BT Group were worth $13,946,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of BT. Barclays PLC lifted its position in BT Group by 377.3% during the first quarter. Barclays PLC now owns 10,500 shares of the utilities provider’s stock valued at $170,000 after purchasing an additional 8,300 shares during the period. Miles Capital Inc. bought a new position in BT Group during the first quarter valued at approximately $174,000. PNC Financial Services Group Inc. lifted its position in BT Group by 79.4% during the first quarter. PNC Financial Services Group Inc. now owns 10,756 shares of the utilities provider’s stock valued at $174,000 after purchasing an additional 4,759 shares during the period. Advisor Group Inc. lifted its position in BT Group by 87.3% during the fourth quarter. Advisor Group Inc. now owns 12,207 shares of the utilities provider’s stock valued at $222,000 after purchasing an additional 5,689 shares during the period. Finally, LPL Financial LLC bought a new position in BT Group during the first quarter valued at approximately $228,000. Institutional investors own 0.92% of the company’s stock.
Top Value Stocks To Watch Right Now: TherapeuticsMD, Inc.(TXMD)
Advisors' Opinion:- [By Logan Wallace]
Swiss National Bank grew its position in shares of TherapeuticsMD Inc (NASDAQ:TXMD) by 4.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 301,400 shares of the company’s stock after purchasing an additional 11,600 shares during the quarter. Swiss National Bank owned approximately 0.14% of TherapeuticsMD worth $1,468,000 as of its most recent SEC filing.
- [By Max Byerly]
TherapeuticsMD Inc (NASDAQ:TXMD) has earned a consensus rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $17.33.
- [By Ethan Ryder]
Shares of TherapeuticsMD Inc (NASDAQ:TXMD) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $14.63.
- [By Cory Renauer]
Shares of TherapeuticsMD (NASDAQ:TXMD), a biopharmaceutical company focused on women's health, jumped 37.8% higher in January, according to data from S&P Global Market Intelligence. Investors were glad to hear the company's new estradiol treatment for dyspareunia due to menopause is off to a better start than originally expected.
Top Value Stocks To Watch Right Now: Acacia Research Corporation(ACTG)
Advisors' Opinion:- [By Stephan Byrd]
Acacia Research Corp (NASDAQ:ACTG) reached a new 52-week low during trading on Wednesday . The company traded as low as $3.00 and last traded at $3.06, with a volume of 4160 shares. The stock had previously closed at $3.15.
- [By Shane Hupp]
Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
- [By Logan Wallace]
These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:
Get Acacia Research alerts: Insider Selling: Acacia Research Corp (ACTG) President Sells 46,143 Shares of Stock (americanbankingnews.com) Insider Selling: Acacia Research Corp (ACTG) President Sells 66,115 Shares of Stock (americanbankingnews.com) Insider Buying: Acacia Research Corp (ACTG) Insider Acquires 10,000 Shares of Stock (americanbankingnews.com) It may surprise you: OncoSec Medical Incorporated (NASDAQ:ONCS), Mizuho Financial Group, Inc. (NYSE:MFG … (thestreetpoint.com)Shares of NASDAQ ACTG traded down $0.05 during midday trading on Tuesday, hitting $3.45. 1,710 shares of the company traded hands, compared to its average volume of 147,059. Acacia Research has a 12-month low of $3.25 and a 12-month high of $5.50. The stock has a market capitalization of $173.23 million, a P/E ratio of 1.16 and a beta of 0.94.
- [By Stephan Byrd]
ValuEngine lowered shares of Acacia Research (NASDAQ:ACTG) from a buy rating to a hold rating in a report published on Wednesday morning.
ACTG has been the topic of a number of other reports. Zacks Investment Research downgraded shares of Acacia Research from a buy rating to a hold rating in a report on Friday, March 23rd. TheStreet downgraded shares of Acacia Research from a c- rating to a d rating in a report on Friday, February 16th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $5.67.
- [By Stephan Byrd]
Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.
- [By Logan Wallace]
These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
Get Acacia Research alerts: Acacia Research to Release Second Quarter Financial Results (finance.yahoo.com) Acacia Research Announces Changes to Board of Directors (finance.yahoo.com) Acacia Research: Miso Robotics’ Kitchen Assistant, Flippy, May Be Worth Flipping Over (seekingalpha.com) Acacia Research (ACTG) Scheduled to Post Quarterly Earnings on Friday (americanbankingnews.com)A number of research analysts have weighed in on ACTG shares. Zacks Investment Research upgraded shares of Acacia Research from a “sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. ValuEngine downgraded shares of Acacia Research from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd.
Top Value Stocks To Watch Right Now: Carrols Restaurant Group Inc.(TAST)
Advisors' Opinion:- [By Ethan Ryder]
Get a free copy of the Zacks research report on Carrols Restaurant Group (TAST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Carrols Restaurant Group (TAST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Carrols Restaurant Group, Inc. (NASDAQ:TAST) VP William E. Myers sold 2,000 shares of the firm’s stock in a transaction on Tuesday, August 21st. The shares were sold at an average price of $16.10, for a total value of $32,200.00. Following the completion of the sale, the vice president now directly owns 72,421 shares of the company’s stock, valued at approximately $1,165,978.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
No comments:
Post a Comment